OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
130 hedge funds and large institutions have $475M invested in Orexigen Therapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 123 → 130 (+7)
Holders
130
Holding in Top 10
–
Calls
$11.7M
Puts
$6.81M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$7.08M | |
| 3 | +$6.02M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.95M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.16M |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$6.47M | |
| 3 | -$5.48M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.23M |
| 5 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$1.94M |